Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09052 | Blinatumomab | 2 | Terminated | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09052 | Blinatumomab | 2 | Terminated | 1 |